Market Summary
Eye Health Supplements Market Overview
The Eye Health Supplements Market was valued at USD 2.31 billion in 2023. The industry is projected to grow from USD 2.42 billion in 2024 to USD 4.07 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.69% during the forecast period (2024 - 2032). The increasing prevalence of eye diseases and growing public awareness on eye conditions are driving the market growth.
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Eye Health Supplements Market Trends
Increasing prevalence of eye diseases
The increasing prevalence of eye diseases has a significant impact on the growth of the eye health supplements industry. According to the World Health Organization (WHO), over 2.2 billion individuals worldwide suffer from visual impairments, with this figure expected to increase to 3.2 billion by 2050. Age-related disorders, including age-related macular degeneration (AMD), cataracts, and diabetic retinopathy, are becoming more common as populations age. For instance, the National Eye Institute (NEI) claims that AMD affects more than 2 million Americans aged 50 and more, with forecasts indicating that figure could double by 2050.
Another critical factor is the rise in diabetes prevalence, which can lead to diabetic eye diseases. According to the Centers for Disease Control and Prevention (CDC), the number of people diagnosed with diabetes has more than tripled in the last 20 years, increasing the risk of diabetic retinopathy. These alarming statistics highlight a critical public health concern, prompting consumers to seek preventive measures such as nutritional supplements that promote eye health.
The increased awareness of the role nutrition plays in sustaining vision is critical in boosting market demand. Research indicates that some nutrients such as lutein, zeaxanthin, omega-3 fatty acids, and vitamins C and E are beneficial for eye health. A study published in the journal Ophthalmology discovered that eating a diet high in these nutrients can reduce the chance of getting AMD and cataracts. The American Academy of Ophthalmology (AAO) also highlights that these nutrients help filter damaging blue light and minimize oxidative stress in the retina. As a result, consumers are increasingly turning to supplements as a handy approach to ensure appropriate consumption of these essential nutrients, particularly for individuals who may not be getting enough from their diet alone.
Furthermore, the growth of digital technology and increased screen time has resulted in a condition known as digital eye strain or computer vision syndrome, which is characterized by symptoms such as dry eyes, impaired vision, and headaches. According to a Vision Council survey, approximately 60% of adults suffer symptoms of digital eye strain, resulting in increased interest in supplements designed to reduce these symptoms. Many of these products claim to provide relief by combining substances proven to boost eye function, making them appealing to a technologically sophisticated population that relies largely on digital devices.
Eye Health Supplements Market Segment Insights
Eye Health Supplements Ingredient Type Insight
Based on ingredient type, the Eye Health Supplements Market has been segmented into lutein and zeaxanthin, antioxidants, omega-3 fatty acids, coenzyme Q10, flavonoids, alpha-lipoic acid, astaxanthin, and others. The Lutein and Zeaxanthin segments held the largest market share in 2023, and the antioxidants segment is the fastest-growing segment during the forecast period (2024 -2032).
Lutein and zeaxanthin products are specifically formulated to support eye health by providing concentrated doses of these beneficial carotenoids. These supplements help protect the eyes from oxidative stress and reduce the risk of age-related macular degeneration (AMD) and cataracts. By filtering harmful blue light, they enhance visual comfort and support overall retinal health. Regular use of lutein and zeaxanthin products can contribute to improved visual performance and long-term eye wellness, making them a valuable addition to a health-conscious lifestyle. According to Effect of Lutein/Zeaxanthin Intake on Human Macular Pigment Optical Density research paper published by Elsevier, In November 2021 has stated that increased lutein/zeaxanthin intake can help with maintaining ocular health. As Lutein, zeaxanthin, and meso-zeaxanthin are the only carotenoids found in the human macula and may have a role in visual function. These carotenoids are reported to protect the retina, and thus vision, as antioxidants and by acting as a blue light filter.
Furthermore, Omega-3 fatty acids play a crucial role in maintaining eye health by potentially reducing the risk of high eye pressure, which is linked to glaucoma. Additionally, these essential fats are beneficial for preventing and treating dry eye syndrome, a common condition characterized by insufficient tear production. Symptoms of dry eye include itching, burning, and redness, and incorporating omega-3 fatty acids into the diet may help alleviate these discomforts while promoting overall ocular health. In May 2024, Asian Journal of Food Research and Nutrition stated that Omega-3 FA are needed for brain and vision development in infants and children, protecting the eye from degenerative damage and conferring anti-inflammatory benefits.
Figure 2: EYE HEALTH SUPPLEMENTS MARKET SIZE, BY INGREDIENT TYPE, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Eye Health Supplements Form Insights
Based on form, the Eye Health Supplements Market has been segmented into capsules, liquid, gummies, Softgel, and others. The capsules segment held the largest market in 2023, and the liquid segment is the fastest growing segment during the forecast period.
Rising preference of capsules to their ease of swallowing and convenience for consumers and increasing availability of specialized formulations in capsule form that enhance bioavailability and absorption of active ingredients is driving the segment.
Eye Health Supplements Application Insights
Based on application, the Eye Health Supplements Market has been segmented into age-related macular degeneration, cataract, glaucoma, eye fatigue, corneal support, eyelid conjunctivitis, and others. The Age-Related Macular Degeneration segment held the largest market in 2023 and the glaucoma segment is the fastest growing segment during the forecast period.
Rising prevalence of age-related macular degeneration (AMD) due to an aging global population, increasing demand of supplements to support retinal health and growing awareness of the role of specific nutrients (like lutein and Zeaxanthin) in reducing the risk of AMD and preserving vision are driving the segment.
Eye Health Supplements Distribution Channel Insights
Based on distribution channel, the Eye Health Supplements Market has been segmented into hospital pharmacy, retail pharmacy, hypermarkets & supermarkets, and e-commerce. The e-commerce segment held the largest market in 2023, and the e-commerce segment is the fastest growing segment during the forecast period.
Eye Health Supplements Regional Insights
Based on region, the Eye Health Supplements Market has been segmented into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America accounted for the largest market share in 2023. However, Asia-Pacific is projected to grow at the highest CAGR of 8.30% during the forecast period.
The Eye Health Supplements market in North America is rapidly evolving, reflecting high awareness of eye health issues and preventative care, especially among aging population. The strong presence of major eye health supplements manufacturers and well-established distribution channel contributes to the Eye Health Supplements market in North America. Furthermore, increasing healthcare expenditure and focus on preventive healthcare, supporting the growth of the supplements market.
The Eye Health Supplements market in Europe is experiencing significant growth, driven by well-regulated market with strong standards, increasing consumer trust in eye health supplements and the presence of leading multinational supplements brands and a robust healthcare infrastructure.
Asia-Pacific region, with countries like India and China, continues to have a growing healthcare and pharmaceutical sectors contribute to market growth. Also, rapidly growing middle class with increased disposable income is boosting the demand for healthcare products, including supplements.
Furthermore, South America is further segmented into the Brazil, Mexico, Argentina, and Rest of South America. The Middle East & Africa is further segmented into GCC Countries, South Africa, and Rest of Middle East & Africa
Figure 3: EYE HEALTH SUPPLEMENTS MARKET BY REGION 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Eye Health Supplements Key Market Players & Competitive Insights
The Eye Health Supplements Market is distinguished by the presence of numerous regional and local players catering to the Eye Health Supplements Market. Furthermore, the increasing prevalence of eye diseases and growing public awareness of eye conditions and the importance of maintaining eye health are the major factors driving the growth of the Eye Health Supplements Market.
The Eye Health Supplements Market is extremely competitive, with players competing and investing heavily in the development of innovative products to gain a significant market share. The market is highly fragmented with high competition in the market, increasing collaborative partnerships, and other strategic decisions to achieve operational efficiency.
The growth of prominent industry players is dependent on various factors, such as market conditions, product differentiation and innovation, and pricing strategies. It is also projected expansion into emerging markets across the globe will also boost the market's growth in the upcoming future.
Major players in the Eye Health Supplements Market, including Bausch + Lomb, Alcon, Nature’s Way, Nordic Naturals, Amway Corp, and others, are making investments in R&D activities to boost market demand.
For Instance, Bausch + Lomb Corporation is a firm that deals with eye health. Its three business segments are ophthalmic drugs, surgical procedures, and eye care. Contact lenses (of which B&L owns 10% of the market) and ocular health products (such as Biotrue and Lumify) make up vision care. Surgical supplies include a variety of intraocular lenses, tools for vitreoretinal and cataract procedures, and surgical instruments. Ophthalmic Pharmaceuticals offers a wide range of medications to address various difficulties, such as Lotemax, Vyzulta, and Xipere. It offers over-the-counter vitamins, contact lenses, ophthalmic medications, lens care supplies, ophthalmic surgery instruments, and eye care items.
Moreover, In September 2022, In the US, Bausch + Lomb Corporation launched Blink NutriTears, an over-the-counter supplement with clinical proof that addresses the primary causes of dry eyes, encourages healthy tear production, and offers noticeable relief from symptoms of dry eyes in as little as two to four weeks.
Key Companies in the Eye Health Supplements Market include
- Herbalife International, Inc. (US)
- Alcon (Switzerland)
- Amway Corp. (US)
- Zeavision, LLC (US)
- Viabiotics Ltd. (UK)
- Vitafusion (US)
- Nature's Way (US)
- Garden of Life (US)
- Bausch + Lomb (Canada)
- Nordic Naturals (US)
Global Eye Health Supplements Industry Developments
June 2024: In the US, Bausch + Lomb Corporation launched Blink NutriTears, an over-the-counter supplement with clinical proof that addresses the primary causes of dry eyes, encourages healthy tear production, and offers noticeable relief from symptoms of dry eyes in as little as two to four weeks..
June 2023: Bausch + Lomb launched PreserVision AREDS 2 Formula soft gels plus coenzyme Q10 in US.
October 2022: In the US, Bausch + Lomb launched Ocuvite Adult 50+, an eye vitamin containing 30 milligrams of vitamin D. This antioxidant has been shown to support normal cell function, which is essential for maintaining the health of the eyes. The Ocuvite Adult 50+ that is now available will be replaced by the improved Ocuvite vitamin.
July 2019: In the US, Bausch + Lomb launched Ocuvite Eye Performance supplements. It is a dietary supplement made to broaden the company's line of eye vitamins while also catering to clients' evolving needs
Eye Health Supplements Market Segmentation
Eye Health Supplements Ingredient Type Outlook
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Eye Health Supplements Form Outlook
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Eye Health Supplements Application Outlook
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Eye Health Supplements Distribution Channel Outlook
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Eye Health Supplements Regional Outlook
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Rest of Europe
-
Asia-Pacific
- China
- Japan
- India
- South Korea
- Malaysia
- Indonesia
- Thailand
- Rest of Asia-Pacific
-
South America
- Brazil
- Mexico
- Argentina
- Rest of South America
-
Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Market Size & Forecast
|
Report Attribute/Metric |
Details |
|
Market Size 2023 |
USD 2.31 billion |
|
Market Size 2024 |
USD 2.42 billion |
|
Market Size 2032 |
USD 4.07 billion |
|
Compound Annual Growth Rate (CAGR) |
6.69% (2024-2032) |
|
Base Year |
2023 |
|
Forecast Period |
2024-2032 |
|
Historical Data |
2019 to 2022 |
|
Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends. |
|
Segments Covered |
Ingredient Type, Form, Application, Distribution Channel, and Region |
|
Key Companies Profiled |
Herbalife International, Inc. (US), Alcon (Switzerland), Amway Corp. (US), Zeavision, LLC (US), Viabiotics Ltd. (UK), Vitafusion (US), Nature's Way (US), Garden of Life (US), Bausch + Lomb (Canada), Nordic Naturals (US) |
|
Key Market Opportunities |
· Expansion into emerging markets. |
|
Key Market Dynamics |
· Increasing prevalence of eye diseases. · Growing public awareness on eye conditions. |
Major Players
Eye Health Supplements Market Segmentation
Global Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Global Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Global Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Global Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Eye Health Supplements Regional Outlook (USD Billion, 2019-2032)
North America Outlook (USD Billion, 2019-2032)
North America Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
North America Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
North America Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
North America Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
US Outlook (USD Billion, 2019-2032)
US Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
US Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
US Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
US Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Canada Outlook (USD Billion, 2019-2032)
Canada Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Canada Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Canada Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Canada Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Europe Outlook (USD Billion, 2019-2032)
Europe Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Europe Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Europe Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Europe Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Germany Outlook (USD Billion, 2019-2032)
Germany Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Germany Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Germany Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Germany Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
France Outlook (USD Billion, 2019-2032)
France Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
France Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
France Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
France Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
UK Outlook (USD Billion, 2019-2032)
UK Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
UK Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
UK Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
UK Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Spain Outlook (USD Billion, 2019-2032)
Spain Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Spain Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Spain Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Spain Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Italy Outlook (USD Billion, 2019-2032)
Italy Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Italy Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Italy Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Italy Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Russia Outlook (USD Billion, 2019-2032)
Russia Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Russia Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Russia Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Russia Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Rest Of Europe Outlook (USD Billion, 2019-2032)
Rest Of Europe Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Rest Of Europe Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Rest Of Europe Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Rest Of Europe Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Asia-Pacific Outlook (USD Billion, 2019-2032)
Asia-Pacific Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Asia-Pacific Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Asia-Pacific Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Asia-Pacific Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
China Outlook (USD Billion, 2019-2032)
China Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
China Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
China Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
China Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Japan Outlook (USD Billion, 2019-2032)
Japan Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Japan Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Japan Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Japan Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
India Outlook (USD Billion, 2019-2032)
India Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
India Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
India Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
India Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
South Korea Outlook (USD Billion, 2019-2032)
South Korea Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
South Korea Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
South Korea Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
South Korea Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Malaysia Outlook (USD Billion, 2019-2032)
Malaysia Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Malaysia Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Malaysia Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Malaysia Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Thailand Outlook (USD Billion, 2019-2032)
Thailand Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Thailand Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Thailand Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Thailand Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Indonesia Outlook (USD Billion, 2019-2032)
Indonesia Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Indonesia Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Indonesia Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Indonesia Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Rest of Asia-Pacific Outlook (USD Billion, 2019-2032)
Rest of Asia-Pacific Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Rest of Asia-Pacific Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Rest of Asia-Pacific Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Rest of Asia-Pacific Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
South America Outlook (USD Billion, 2019-2032)
South America Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
South America Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
South America Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
South America Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Brazil Outlook (USD Billion, 2019-2032)
Brazil Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Brazil Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Brazil Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Brazil Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Mexico Outlook (USD Billion, 2019-2032)
Mexico Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Mexico Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Mexico Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Mexico Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Argentina Outlook (USD Billion, 2019-2032)
Argentina Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Argentina Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Argentina Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Argentina Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Rest of South America Outlook (USD Billion, 2019-2032)
Rest of South America Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Rest of South America Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Rest of South America Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Rest of South America Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Middle East & Africa Outlook (USD Billion, 2019-2032)
Middle East & Africa Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Middle East & Africa Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Middle East & Africa Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Middle East & Africa Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
GCC Countries Outlook (USD Billion, 2019-2032)
GCC Countries Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
GCC Countries Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
GCC Countries Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
GCC Countries Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
South Africa Outlook (USD Billion, 2019-2032)
South Africa Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
South Africa Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
South Africa Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
South Africa Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Rest of Middle East & Africa Outlook (USD Billion, 2019-2032)
Rest of Middle East & Africa Eye Health Supplements Ingredient Type Outlook (USD Billion, 2019-2032)
- Lutein and Zeaxanthin
- Antioxidants
- Omega-3 Fatty Acids
- Coenzyme Q10
- Flavonoids
- Alpha-Lipoic Acid
- Astaxanthin
- Others
Rest of Middle East & Africa Eye Health Supplements Form Outlook (USD Billion, 2019-2032)
- Capsules/Tablets
- Liquid
- Gummies
- Softgel
- Powder
Rest of Middle East & Africa Eye Health Supplements Application Outlook USD Billion, 2019-2032)
- Age-related Macular Degeneration
- Cataract
- Glaucoma
- Eye Fatigue
- Corneal Support
- Eyelid Conjunctivitis
- Others
Rest of Middle East & Africa Eye Health Supplements Distribution Channel Outlook (USD Billion, 2019-2032)
- Hospital Pharmacy
- Retail Pharmacy
- Hypermarkets & Supermarkets
- E-Commerce
Leave a Comment